missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Protein S Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5110737
This item is not returnable.
View return policy
Description
Immunogen sequence: QGASGIKEII QEKQNKHCLV TVEKGSYYPG SGIAQFHIDY NNVSSAEGWH VNVTLNIRPS TGTGVMLALV SGNNTVPFAV SLVDSTSEKS QDILLSVENT VIYRIQALSL CSDQQSHLEF RVNR.
Protein S is a vitamin K-dependent, potent neutral anticoagulant plasma glycoprotein. Protein S has a molecular weight of approximately 70 kDa and consists of a single polypeptide chain. The concentration of protein S in human plasma is 25 μg/mL, with a half-life of approximately two days. About 40% of Protein S in plasma is in a free form, whereas 60% is complexed with C4b-binding Protein (C4BP). Only the free Protein S functions as a cofactor to antigen presenting cells (APC) in the APC-dependent degradation of Factor Va and Factor VIIIa.
Specifications
| Protein S | |
| Polyclonal | |
| Unconjugated | |
| PROS1 | |
| AW214361; Preproprotein S; PROS; PROS 1; PROS1; protein S; protein S (alpha); Protein S alpha; protein Sa; proteinS; PS 21; PS 22; PS 23; PS 24; PS 25; PS 26; PS21; PS22; PS23; PS24; PS25; PS26; PSA; rabbit protein S; THPH5; THPH6; unnamed protein product; vitamin K-dependent plasma protein S; vitamin K-dependent protein S; vitamin K-dependent protein S precursor | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 5627 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| P07225 | |
| PROS1 | |
| Recombinant Protein corresonding to Human Protein S. Recombinant protein control fragment (Product #RP-100455). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction